Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease

Journal of Nephrology

Volumn 19, Issue 6, 2006, Pages 802-807

  Babel, Nina ^a   Gabdrakhmanova, Leila ^a   Hammer, Markus H ^a   Schoenemann, Constanze ^a   Skrypnikov, Volodimir ^a   Poliak, Nina ^b   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Cytokine gene polymorphism; ESRD; IL 10; TGF 1

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GLOMERULONEPHRITIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOPATHOGENESIS; KIDNEY FAILURE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; AGED; CYTOKINES; DIABETIC NEPHROPATHIES; FEMALE; GERMANY; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33947269973     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Vandenbroeck K, Goris A. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci 2003; 24: 284-9.
2. Freedman B. Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 2003; 14: S192-4.
3. Freedman BI, Bowden DW, Rich SS, Appel RG. Genetic initiation of hypertensive and diabetic nephropathy. Am J Hypertens 1998; 11: 251-7.
4. Bensen JT, Langefeld CD, Li L, McCall CE, Cousart SL, Dryman BN, Freedman BI, Bowden DW. Association of an IL-1A 3′UTR polymorphism with end-stage renal disease and IL-1a expression. Kidney Int 2003; 63: 1211-9.
5. Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S, Tanaka Y, Masutani K, Hirakata H, Gondo H, Otsuka T, Harada M. Genetically determined interferon-g production influences the histological phenotype of lupus nephritis. Rheumatology 2002; 41: 518-24.
6. Rovin BH, Lu L, Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002; 62: 261-5.
7. Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 2002; 61: 1079-85.
8. Masutani K, Miyake K, Nakashima H, Hirano T, Kubo M, Hirakawa M, Tsuruuuuuya K, Fukuda K, Kanai H, Otsuka T, Hirakata H, Iida M. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 2003; 41: 371-9.
9. Blakemore AIF, Cox A, Gonzalez A-M, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-74.
10. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi, Ishii M, Yuno M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T. Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in Type 2 diabetes. Diabet Med 2002; 19: 1000-5.
11. Wong TYH, Poon P, Chow KM, Szeto CC, Cheung MK, Li PKT. Association of transforming growth factor-beta (TGF-β) T869C (Leu10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int 2003; 63: 1831-5.
12. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M. Promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. Diabetes 2003; 52: 1872-6.
13. Coll E, Cormand B, Campos B, Gonzalez-Nunez D, Inigo P, Botey A, Poch E. Association of TGF-beta1 polymorphisms with chronic renal disease. J Nephrol 2004; 17: 794-9.
14. Border WA, Noble NA. Cytokines in kidney disease: the role of transforming growth factor-beta. Am J Kidney Dis 1993; 22: 105-13.
15. Ng DP, Warram JH, Krolewski AS. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis 2003; 41: 22-8.
16. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014-20.
17. Chow KM, Szeto CC, Poon P, Lau WY, Lai FM, Li PK. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients. Ren Fail 2005; 27: 671-5.
18. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphisms distribution. Am J Transplant 2002; 2: 560-7.
19. Turner D, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997; 24: 1-8.
20. Hutchinson IV, Turner D, Sankaran D, Awad M, Pravica V, Sinnott PJ. Cytokine genotypes in allograft rejection: guidelines for immunosuppression. Transplant Proc 1998; 30: 3991-2.
21. Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281-8.
22. Cartwright NH, Demaine AG, Hurlock NJ, McGonigle RJ, Rowe PA, Shaw JF, Szydlo RM, Kaminski ER. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transplant Immunol 2000; 8: 109-14.
23. Pelletier R, Pravica V, Perrey C, Xia D, Ferguson RM, Hutchinson I, Orosz C. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000; 70: 674-80.
24. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-66.